MHRP and collaborators recently launched a Phase 1 trial in Thailand that will evaluate two HIV vaccine candidates with and without the Army's novel ALFQ adjuvant to gain insight into late boosting strategies and the effects of fractional dosing.
MHRP’s African Cohort Study (AFRICOS), a multisite, long-term study that evaluates HIV prevention, care and treatment services it supports through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), is entering its ninth year in 2022. Over the past year, MHRP researchers and collaborators published 13 papers in peer-reviewed journals. A sampling of cohort research reveals the breadth of research conducted under AFRICOS:
February 11 is International Women and Girls in Science Day, a day to create awareness of the STEM gap and recognize the roles women in STEM play in advancing their fields.
The Walter Reed Program-Nigeria (WRP-N) has completed the pilot phase of a PEPFAR-funded initiative to conduct community-led monitoring of HIV services across 10 states in Nigeria.
